Masayuki Tomioka
Papers
8
Total Citations
36
H-Index
4
About
Masayuki Tomioka is a urologic surgeon and researcher whose work centers on advancing surgical and multimodal treatments for prostate and bladder cancers. His primary contributions lie in evaluating robot-assisted radical prostatectomy (RARP) for high-risk and metastatic prostate cancer, including its role as cytoreductive therapy in patients with metastatic disease—a frontier with potential to improve oncological outcomes. Tomioka has also investigated chemohormonal therapy regimens, such as neoadjuvant LHRH antagonists combined with tegafur-uracil, to optimize treatment before surgery. In bladder cancer, he has explored split-dose cisplatin-based neoadjuvant chemotherapy and intracorporeal urinary diversion techniques following robot-assisted cystectomy. His most cited work (9 citations each) examines RARP for metastatic prostate cancer and biochemical recurrence after chemohormonal therapy. With over 35 cumulative citations across his top papers, Tomioka’s research is shaping protocols for aggressive urologic cancers, offering insights into surgical precision, perioperative safety, and long-term cancer control.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8